ANKMJ

Ankyra Medical Journal (AnkMJ), formerly known as the Journal of Translational and Practical Medicine, regularly publishes international quality issues in the field of Medicine in the light of current information.

EndNote Style
Index
Case Report
Phenotypic characterization of CRB1-associated Leber congenital amaurosis in two siblings: emphasis on para-arteriolar RPE preservation
Leber congenital amaurosis (LCA) associated with CRB1 mutations exhibits a distinct retinal phenotype, most notably para-arteriolar retinal pigment epithelium preservation (PPRPE), an important yet often under-recognized diagnostic hallmark. We report two affected female siblings from a consanguineous family who underwent comprehensive multimodal ophthalmic evaluation, including best-corrected visual acuity assessment, color fundus photography, spectral-domain optical coherence tomography (OCT), fundus autofluorescence (FAF), and full-field electroretinography (ERG). Both demonstrated congenital severe visual impairment and nystagmus. Fundus examination revealed bilateral nummular pigmentation with characteristic PPRPE, while FAF showed para-arteriolar hyperautofluorescence consistent with preserved RPE integrity. OCT demonstrated diffuse retinal thinning, macular disorganization, and peripheral atrophy, and ERG responses were markedly reduced or extinguished. Next-generation sequencing identified a homozygous pathogenic CRB1 variant, c.2843G>A, p.(Cys948Tyr) (NM_201253), classified as pathogenic according to ACMG-2015 criteria, confirming CRB1-associated LCA. Additional affected male family members further supported autosomal recessive inheritance. The coexistence of PPRPE, macular structural abnormalities, and severe electrophysiological dysfunction aligns with the established CRB1 phenotypic spectrum. These findings reinforce the diagnostic utility of PPRPE in differentiating CRB1-associated LCA from other molecular subtypes and underscore the importance of integrating multimodal imaging with early molecular testing to facilitate accurate diagnosis, targeted genetic counseling, and potential future eligibility for emerging genotype-directed therapies.


1. den Hollander AI, Roepman R, Koenekoop RK, Cremers FPM. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res. 2008;27(4):391-419. doi:10.1016/j.preteyeres.2008.05.003
2. Bujakowska KM, Audo I, Mohand-Saïd S, et al. CRB1 mutations in inherited retinal dystrophies. Prog Retin Eye Res. 2012;31(2):120-147. doi:10.1016/j.preteyeres.2012.01.001
3. Stone EM. Leber congenital amaurosis—a model for efficient genetic testing via NGS panels. Ophthalmology. 2017;124(7):1062-1064. doi:10. 1016/j.ophtha.2017.03.001
4. Pellissier LP, Alves CH, Quinn PM, et al. Targeted disruption of the CRB1 gene in mice reproduces the retinal phenotype associated with CRB1 mutations in humans. Hum Mol Genet. 2013;22(1):35-48. doi:10. 1093/hmg/dds399
5. Alves CH, Pellissier LP, Vos RM, et al. CRB1: A master regulator of photoreceptor-Müller glia interaction. Hum Mol Genet. 2014;23(20): 5359-5370. doi:10.1093/hmg/ddu251
6. Galvin JA, Fishman GA, Stone EM, et al. CRB1-associated retinal dystrophies: clinical and imaging characteristics. Retina. 2020;40(3): 469-480. doi:10.1097/IAE.0000000000002372
7. den Hollander AI, Heckenlively JR, van den Born LI, et al. CRB1 mutations and para-arteriolar pigment preservation in LCA. J Med Genet. 2001;38(2):109-113. doi:10.1136/jmg.38.2.109
8. Nguyen X-T, Birtel J, Gliem M, et al. Imaging features of CRB1-LCA: a multimodal approach. Ophthalmic Genet. 2022;43(4):440-450. doi:10. 1080/13816810.2022.2070697
9. Cideciyan AV, Aleman TS, Jacobson SG, et al. CEP290-LCA: Imaging and functional phenotype. Invest Ophthalmol Vis Sci. 2007;48(9):4001-4009. doi:10.1167/iovs.07-0412
10. Jacobson SG, Cideciyan AV, Roman AJ, et al. Natural history of RPE65-LCA. Ophthalmology. 2020;127(10):1393-1404. doi:10.1016/j.ophtha. 2020.03.012
11. Talib M, van Schooneveld MJ, van Genderen MM, et al. Structural OCT characteristics in CRB1-linked early-onset retinal dystrophy. Br J Ophthalmol. 2017;101(5):627-634. doi:10.1136/bjophthalmol-2016- 309376
12. McCulloch DL, Marmor MF, Brigell MG, et al. ISCEV Standard for clinical electroretinography. Doc Ophthalmol. 2022;144(3):209-245. doi: 10.1007/s10633-022-09864-5
13. Consugar MB, Navarro-Gomez D, Place EM, et al. Clinical NGS testing in hereditary retinal disorders. Hum Mutat. 2015;36(6):591-602. doi:10. 1002/humu.22781
14. Kumaran N, Moore AT, Weleber RG, et al. Gene therapy prospects for CRB1-associated retinal dystrophies. Hum Gene Ther. 2020;31(11-12): 702-716. doi:10.1089/hum.2020.29020.nku
15. Quinn N, Csincsik L, Flynn E, et al. CRB1-associated retinal dystrophies: expanding phenotypes. Ophthalmology. 2019;126(11):1546-1558. doi:10.1016/j.ophtha.2019.05.012
16. Chen Y, Zeng C, Wang C, et al. Structural-functional correlation in CRB1 retinopathy. Retina. 2019;39(6):1171-1181. doi:10.1097/IAE. 0000000000002100
Volume 5, Issue 2, 2026
Page : 56-60
_Footer